Loading...
Many recent observational studies suggest associations between proton-pump inhibitor (PPI) use and a host of different disorders (NEJM JW Gastroenterol Jun 13 2017; [e-pub] and Gastroenterology 2017 May 18; [e-pub]).
To evaluate whether PPI use is associated with chronic kidney disease (CKD), researchers retrospectively analyzed serum creatinine measurements in approximately 100,000 new PPI users and 10,000 new users of histamine-2–receptor antagonists (H2RAs) in a cohort of Swedish patients. Median follow-up was 2.7 years after initial drug exposure.
PPI users were more likely to have a doubling of serum creatinine (hazard ratio, 1.3) or a 30% decrease in estimated glomerular filtration rate (EGFR; HR, 1.3) compared with nonusers. The associ…